Support teaching, research, and patient care.
Dr. Langston joined the faculty in the Department of Epidemiology and Population Health in 2022. He received his PhD in Epidemiology from the University of Arizona’s College of Public Health followed by postdoctoral training in Cancer Prevention and Control at Washington University in Saint Louis School of Medicine. Dr. Langston focuses on the epidemiology of benign and malignant prostate conditions. His long-term goal is to harmonize molecular and clinical aspects of urological condition diagnoses to produce well-characterized outcomes for biomarker discovery and etiological investigation.
This project will compare the effectiveness of pharmacological therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia in preventing long-term disease progression; and develop and validate predictive models using demographic, clinical, and laboratory data available at the time of diagnosis to identify patients at increased risk of long-term disease progression.
Postoperative urinary retention (POUR) is the inability to void despite a full bladder following a surgical procedure. POUR can result in painful catherization, increased patient distress, increased postoperative hospital stay, urinary tract infections, detrusor muscle dysfunction, and cardiac arrhythmias. This research will lead to the development of a preoperative tool that can risk stratify patients based on risk factors for POUR and help providers develop a care plan to reduce patients' risk.